Journal profile · RHEUMATOLOGY
ARP Rheumatology
ISSN 2795-4552 · Sociedade Portuguesa de Reumatologia
ARP Rheumatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.2; diamond open access (no APC); no APC; review about 31 days (first decision after review, publisher); acceptance rate 16% (journal website); 58 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ARP Rheumatology is published by Sociedade Portuguesa de Reumatologia and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Sclerosis and Related Diseases and Spondyloarthritis Studies and Treatments, together about 37.3% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal ARP Rheumatology succeeds Acta Reumatológica Portuguesa, originally founded in 1973 as the official journal of the Portuguese Society of Rheumatology. It is a scientific double-blinded peer-reviewed and open-access journal devoted to progress in the research, diagnosis and treatment of rheumatic and musculoskeletal diseases. Both basic research and clinical papers may be submitted. The journal aims at serving the interest of both practising clinicians and research workers. Editorials, short communications and review articles covering recent developments are included. Controversial techniques and issues on health policy are frequently discussed and serve as tools for encouraging debate. It also concerns about guidelines and clinical protocols related to the practice of rheumatology.
From the journal's Aims & Scope
Research area (LetPub): RHEUMATOLOGY
Editor-in-chief Tânia SantiagoPublisher website
Editorial board by country: none in mainland China; most named Portugal 6, United Kingdom 2, Netherlands 2, Italy 1, Spain 1 (13 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine16.4%
- Systemic Sclerosis and Related DiseasesMedicine10.7%
- Spondyloarthritis Studies and TreatmentsMedicine10.2%
- Systemic Lupus Erythematosus ResearchMedicine6.7%
- Vasculitis and related conditionsMedicine6.7%
- Autoimmune and Inflammatory Disorders ResearchMedicine6.2%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.8%
- Inflammatory Myopathies and DermatomyositisMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.2LetPub ·
- Impact factor (publisher)
- 1.7Publisher website ·
- 5-year impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- CiteScore (publisher)
- 2.1Publisher website ·
- SJR 2026-06
- 0.42LetPub ·
- SNIP 2026-06
- 0.51LetPub ·
- h-index
- 5OpenAlex ·
- i10-index
- 1OpenAlex ·
- 2-year mean citedness
- 1.05OpenAlex ·
- Self-citation rate
- 15.4%LetPub ·
- Share of gold OA articles
- 61.39%LetPub ·
Volume
- Articles per year
- 31LetPub ·
Articles by year OpenAlex count · 145 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 24 | 4 |
| 2025 | 58 | 58 | 42 |
| 2024 | 61 | 61 | 104 |
| 2023 | 2 | 2 | 4 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
31 daysfirst decision after review
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Acceptance rate (publisher)
- 16%Publisher website ·
- Desk decision
- 2 daysPublisher website ·
- First decision after review
- 31 daysPublisher website ·
- Submission to publication
- 74 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 350 words
- Keywords
- ≥ 5
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- Templates
- Word
- Suggested reviewers
- Optional, 3
- Cover letter
- Required
Article types accepted5, with length limits
- correspondenceUp to 1000 words, commenting on an article published at ARP Rheumatology within 6 months. Instructionsmain text ≤ 1,000 words
- editorialrticles published in that issue of ARP. Editorials should not exceed 1200 words, with a maximum of 15 references and one Table or Figure; -main text ≤ 1,200 words
- original articles, Results, Discussion and Conclusions. Original articles should not exceed 4,000 words, 6 Tables or Figures and 60 references; - Clinical Practicemain text ≤ 4,000 words
- protocolteam Clinical practice, rules or action protocols Recommendations for Clinical Practice Correspondence & Reply Up to 1000 words, commenting on an article publis…main text ≤ 1,000 words
- review articleicle are welcome to contact the Editor. Review articles should not exceed 4,000 words, 6 Tables or Figures and 100 references; - Original articlemain text ≤ 4,000 words
Policy excerpts from the journal's websitePublication ethics, Open access, Peer review
- Publication ethics
Originality requirement; no prior publication. Model summary
Papers submitted to ARP Rheumatology must be original and cannot be previously published elsewhere.
Source ↗Publisher website ·- Open access
Copyright transfer to journal; green open access deposit allowed without embargo. Model summary
Upon acceptance for publication, authors transfer the copyrights interests of the manuscript to ARP Rheumatology. Authors are authorised to deposit all the versions of the article (submitted, accepted or published version) in an institutional repository without embargo, as long as they mention where they were published.
Source ↗Publisher website ·- Peer review
Editorial policy follows Council of Science Editors Editorial Policy Statements. Model summary
The editorial policy of ARP Rheumatology follows the Editorial Policy Statements published by the Council of Science Editors.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Sociedade Portuguesa de Reumatologia
- ISSN
- 2795-4552
- Society / sponsor
- Portuguese Society of Rheumatology
- Official links
FAQ
Frequently asked questions about ARP Rheumatology
What CAS zone is ARP Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, ARP Rheumatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ARP Rheumatology?
The latest impact factor listed by LetPub is 1.2; CiteScore 2.1, h-index 5.
How long does peer review take at ARP Rheumatology?
The publisher reports about 31 days (first decision after review); the journal's website gives an acceptance rate of 16%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ARP Rheumatology?
According to the journal's author guidelines: Abstract: ≤ 350 words; Keywords: ≥ 5; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; Templates: Word; Suggested reviewers: Optional, 3; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of ARP Rheumatology based?
Of the 13 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Portugal (6), United Kingdom (2) and Netherlands (2). Counted from the institutions listed on the board page; for reference only.
Which databases index ARP Rheumatology?
According to LetPub and DOAJ records, ARP Rheumatology is indexed in SCIE, Scopus and DOAJ.
Is ARP Rheumatology open access, and what is the APC?
ARP Rheumatology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .